Other

Cumulative amount of fair value hedging adjustment

Amgen Cumulative amount of fair value hedging adjustment decreased by 13.7% to -$183.00M in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2025
Last reportedQ1 2026
Metric ID: other_hedged_liability_fair_value_hedge_cumulative_incre_c9d377

Historical Data

2 periods
 Q4 '25Q1 '26
Value-$161.00M-$183.00M
QoQ Change—-13.7%
Range-$183.00M – -$161.00M

Cumulative amount of fair value hedging adjustment at Other Companies

Pfizer logo
PfizerPFEView metric
Merck & Co. logo
Merck & Co.MRKView metric

Frequently Asked Questions

What is Amgen's cumulative amount of fair value hedging adjustment?
Amgen (AMGN) reported cumulative amount of fair value hedging adjustment of -$183.00M in Q1 2026.